Le Lézard
Classified in: Health
Subjects: MAV, CFG

UPDATE - Media Advisory - Prime Minister's itinerary for Friday, October 23, 2020


OTTAWA, ON, Oct. 23, 2020 /CNW/ -

Note: All times local

Ottawa, Ontario



Private meetings.



11:30 a.m.    

The Prime Minister will make an announcement and hold a media availability. President of the Treasury Board Jean-Yves Duclos, President of the Queen's Privy Council for Canada and Minister of Intergovernmental Affairs Dominic LeBlanc, Minister of Public Services and Procurement Anita Anand, Chief Public Health Officer of Canada Dr. Theresa Tam, and Deputy Chief Public Health Officer of Canada Dr. Howard Njoo will be in attendance.




Room 200


Sir John A. Macdonald Building


144 Wellington Street




Notes for media:




  • Open coverage
  • Media wishing to cover the event must be accredited with the Parliamentary Press Gallery.
  • Journalists can dial in to listen and ask questions.
  • Participant dial-in numbers:
    Local: 613-954-9003
    Toll-free: 1-866-206-0153
    Pass code: 6822783#


Media appearances



8:10 a.m. 

An interview with the Prime Minister will air live on 94.3 CKSY.



9:10 a.m. 

An interview with the Prime Minister will air on CBC Radio One St. John's.

This document is also available at http://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 21:59
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 21:27
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:19
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral...

at 21:02
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the company's three key...

at 19:59
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...



News published on and distributed by: